Upregulation of long noncoding RNA ANRIL correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma [0.03%]
长非编码RNA ANRIL的上调与食管鳞状细胞癌的肿瘤进展及不良预后相关
Tinghua Cao,Jiaqing Shen,Wenbin Pan et al.
Tinghua Cao et al.
Purpose: Esophageal cancer (EC) is the 9th most common carcinoma worldwide with poor prognosis. Specific biomarkers can help predicting the development of esophageal squamous cell carcinoma (ESCC), which can improve the a...
The risk factors about prognosis of 142 GIST patients with recurrence or metastasis: A retrospective study of single centre in Northern China [0.03%]
北方单中心142例复发/转移胃肠道间质瘤患者预后影响因素的回顾性分析
Yong Li,Bibo Tan,Haifeng Wu et al.
Yong Li et al.
Purpose: In this retrospective study, we investigated the clinicopathologic features, prognosis as well as the factors contributing to prognosis of patients with metastatic or recurrent gastrointestinal stromal tumors (GI...
Clinicopathological characteristics of patients with multiple primary neoplasms-a retrospective analysis [0.03%]
多原发肿瘤患者的临床病理特征回顾性分析
Adina Nemes,Nicolae Todor,Viorica Nagy
Adina Nemes
Purpose: Multiple primary neoplasms (MPN) represent the occurrence of two or more primary neoplasms in the same individual during lifetime and today there is an increased interest in studying the implications of MPN in th...
Cycloartenol exerts anti-proliferative effects on Glioma U87 cells via induction of cell cycle arrest and p38 MAPK-mediated apoptosis [0.03%]
环阿特诺醇通过诱导细胞周期阻滞和p38MAPK介导的凋亡对胶质瘤U87细胞产生抗增殖作用
Huanfu Niu,Xinming Li,Aijun Yang et al.
Huanfu Niu et al.
Purpose: Gliomas are destructive malignancies affecting mainly the central nervous system. Gliomas constitute around 50% of all the central nervous system tumors. The purpose of this study was to examine the anticancer ac...
Induction of apoptosis in human acute monocytic leukemia (THP-1) cells with NaF and the related mechanisms [0.03%]
氟化钠诱导人急性单核细胞白血病(THP-1)细胞凋亡及其机制研究
Hongmei Jiang,Peng Fang,Guoping Zhang
Hongmei Jiang
Purpose: Acute monocytic leukemia remains a big challenge, and there are a series of non-specific esterases which can be inhibited by sodium fluoride (NaF) in mononuclear cells, providing insights into the leukemia target...
Long non-coding RNA H19 promotes proliferation of Hodgkin's lymphoma via AKT pathway [0.03%]
长链非编码RNA H19通过AKT途径促进霍奇金淋巴瘤增殖
Yan Wang,Li Wang,Minghua Sui
Yan Wang
Purpose: To explore whether lncRNA (Long non-coding RNA) H19 could promote the development of Hodgkin's lymphoma (HL) by regulating cell proliferation via AKT pathway. ...
MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2 [0.03%]
miR-199b-5p通过调控HER2促进骨肉瘤恶性进展
Zi Chen,Guohui Zhao,Yunkun Zhang et al.
Zi Chen et al.
Purpose: MicroRNAs (miRs) are endogenous, noncoding small RNAs that play a key role in regulating biological and pathological processes. The oncogenic properties of miR-199b-5p have been demonstrated in previous studies b...
Retrospective analysis of the effect of treatment of osteosarcoma complicated by pathological fracture by neoadjuvant chemotherapy combined with limb salvage surgery [0.03%]
新辅助化疗结合保肢手术治疗骨肉瘤合并病理性骨折的疗效回顾性分析
Junke Zhu,Tianda He,Zhaoxiang Wei et al.
Junke Zhu et al.
Purpose: To explore the efficacy of neoadjuvant chemotherapy combined with limb salvage surgery for the treatment of osteosarcoma complicated by pathological fracture. ...
Aspirin use improves the biochemical control of prostate cancer in Chinese men [0.03%]
阿司匹林的使用可以改善中国男性前列腺癌的生物化学控制效果
Qiang Hao,Haiying Gong,Huantao Zong et al.
Qiang Hao et al.
Purpose: Aspirin may improve treatment outcomes and increase the survival of patients with prostate cancer, but the results remain controversial. Methods:...
The expression of PD-L1 in patients with castrate prostate cancer treated with enzalutamide [0.03%]
恩扎卢胺治疗去势抵抗性前列腺癌患者PD-L1的表达
Igor Richter,Tomas Jirasek,Ivana Havlickova et al.
Igor Richter et al.
Purpose: The purpose of our retrospectively study was to evaluate the PD-L1 expression in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide. ...